Maynard Um
-
-
-
-
-
-
-
CureVac N.V. (CVAC) announces AGM results
-
-
-
-
-
-
-
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update
-
-
-
-
-
-
-
CureVac Earns Repeat Recognition by LexisNexis(R) as One of the World’s Top Innovators
-
-
-
-
-
-
-
CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer
-
-
-
-
-
-
-
CureVac to Present First CVGBM Glioblastoma Cancer Vaccine Clinical Data at ESMO 2024 Congress
-
-
-
-
-
-
-
CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech
-
-
-
396,362 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

